Chapter 10

Discovery of an Effective Ricin Antidote: An Old Drug for a New Use

Junfei Yin, Michael Fung and John W. Cherwonogrodzky

Abstract

A cell-based high throughput screening assay (HTS) was established to screen the Prestwick Chemical Library for candidates that acted against ricin. Of 1120 compounds screened, only 7 were identified as ricin inhibitors. Secondary screening with cell cultures identified only ethotoin as a dose-dependent inhibitor against ricin induced toxicity. Ethotoin was further evaluated in two in vivo studies. Study 1: When mice were given intra-peritoneal injections of 5×LD50 ricin (1 μg) pre-incubated with ethotoin (1 mg), all mice survived (monitored for 14 days). In contrast, control mice without ethotoin died within 2 days. Study 2: When mice were given 2×LD50 ricin (0.2 μg) by the intranasal route and then given ethotoin by multiple oral/gavage deliveries (at 1, 2, 4, 6, 8 and 10 hr after intoxication) 40% of the mice were alive at day 14. In contrast, all control mice (those that received sterile saline instead) died between days 3-9. Hence ethotoin, given by one route (oral) could rescue some mice from ricin given by another route (intra-nasal). Our findings suggest that ethotoin, although now an abandoned anti-convulsant drug, deserves further investigation and development as a potential antidote against the ricin biothreat.

Total Pages: 182-196 (15)

Download Free  Book Details

RELATED BOOKS

.Endocannabinoids: Molecular, Pharmacological, Behavioral and Clinical Features.
.Frontiers in Clinical Drug Research- HIV.
.Frontiers in Clinical Drug Research-Anti-Infectives.
.Endocannabinoids: Molecular, Pharmacological, Behavioral and Clinical Features.
.Solubility, Delivery and ADME Problems of Drugs and Drug-Candidates.
.
            The Pharmaceutical Scientist Guide to Solution Kinetic Models Mathematical Description and Applications.